Oh, the places you'll go

Two Harvard labs have collaborated to track nanoparticle dynamics in tumors through in vivo imaging. In a pair of studies, the teams highlighted how the efficacy of nanomedicines could be influenced and predicted by the spatial distribution of nanoparticles in tumors.

Omid Farokhzad, a principal investigator on both studies, thinks such spatial information will be critical to jump-start what he believes is a promising but stunted field. "If you look across the field of nanomedicine and ask, can you name a nanomedicine that has made a material difference in extending the lives of patients, then I think the answer is no I cannot," he said...